Food Standards Agency
Insufficient evidence for vitamin D preventing or treating acute respiratory tract infections
The Scientific Advisory Commission on Nutrition (SACN) and the National Institute for Health and Care Excellence (NICE) yesterday published their rapid reviews exploring the role of Vitamin D supplementation in reducing the risk of Acute Respiratory Tract Infections (ARTIs) and the prevention and treatment of COVID-19.
Vitamin D is needed to keep bones and muscles healthy. The current UK government advice is that everyone should take a daily 10 microgram vitamin D supplement to protect musculoskeletal health. It has also been suggested that vitamin D could reduce the risk of ARTIs and COVID-19.
Public Health England (PHE) commissioned SACN to examine new evidence on whether vitamin D supplementation could reduce the risk of ARTIs and supported NICE to review emerging evidence on vitamin D and the prevention and treatment of COVID-19.
SACN rapid review
SACN’s rapid review (Opens in a new window) assessed evidence on vitamin D and ARTIs that had been published since the last SACN review in 2016. ARTIs refers to any infection of the sinuses, throat, airways or lungs. The review did not look specifically at the effect of vitamin D supplementation on COVID-19 risk. The review concluded that evidence currently does not support vitamin D supplementation to prevent ARTIs in the general UK population. The review reiterates the importance of vitamin D for bone and muscle health.
Sunlight is the primary source of Vitamin D. That is why with ‘stay at home’ measures in place the UK Government re-issued advice (Opens in a new window) at the beginning of April 2020 that everyone takes a daily vitamin D supplement to mitigate the effects of reduced time outdoors.
NICE rapid evidence summary
PHE also supported NICE to conduct a rapid evidence summary (Opens in a new window) evaluating emerging evidence on vitamin D in relation to COVID-19. The review concluded that there is currently no evidence to support taking vitamin D supplements to reduce the risk or severity of COVID-19.
PHE, SACN and NICE are aware that a systematic review and controlled trials on vitamin D and COVID-19 are underway and will continue to monitor and assess new evidence as it is published.
Latest News from
Food Standards Agency
FSA publishes its Annual Report and Accounts for 2019/2002/07/2020 15:38:00
The Food Standards Agency (FSA) has today published its Northern Ireland Annual Report and Accounts for the past financial year. The report covers our performance and activities in 2019/20 across England, Wales and Northern Ireland at a net cost of £112.6 million.
Food Standards Agency blog launches30/06/2020 16:51:00
Food Standards Agency yesterday launched their official blog.
Covid-19 Consumer Tracker waves one and two report published25/06/2020 13:38:00
The Food Standards Agency (FSA) yesterday published the findings for waves one and two of the Covid-19 Consumer Tracker.
FSA Board pays tribute to food and feed industries for ‘an outstanding job in keeping food on the shelves’22/06/2020 14:25:00
The COVID-19 pandemic was one of the main topics of discussion as the Food Standards Agency (FSA) Board met this week for the first time since 11 March.
Primula recalls all Primula Cheese tubes because of Clostridium botulinum19/06/2020 12:08:00
Primula Ltd is recalling all Primula Cheese tubes, (chilled and ambient) because the product might be contaminated with Clostridium botulinum due to a production fault.
FSA publishes updated allergen guidance to reflect changes to labelling laws19/06/2020 11:43:00
Updated technical guidance follows changes to food allergen labelling which come into effect from October 2021.
Dr Ruth Hussey is appointed Food Standards Agency Deputy Chair18/06/2020 11:43:00
The Secretary of State for Health has announced the appointment of Dr Ruth Hussey CB, OBE, DL as Deputy Chair of the Food Standards Agency. Her appointment begins on 1 July for three years.
FSA outlines role of science in protecting consumers’ interests post-EU transition18/06/2020 10:43:00
Professor Guy Poppy, our outgoing Chief Scientific Adviser yesterday published his final CSA report focusing on the role of science and evidence in our risk analysis process.